Supernus Pharmaceuticals Inc (SUPN)
Operating Income Growth
-274.34%
TTM · Period ending:
SUPN Operating Income Growth
Year-over-year change vs the same period a year earlier
Latest reported-274.34%period ending
Latest reported-274.34%period ending
SUPN TTM Operating Income YoY % (6.98% → -274.34%)
Year-over-year change
High-resolution chart · PNG
SUPN operating income growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Operating Income Growth |
|---|---|
| -274.3401% | |
| -155.9379% | |
| -154.5196% | |
| -162.3319% | |
| 141.4903% | |
| 648.338% | |
| 1,649.9336% | |
| 97.1491% | |
| 30.1863% | |
| -127.5637% | |
| -111.4236% | |
| 68.0512% | |
| -60.7805% | |
| -34.0309% | |
| -46.3855% | |
| -85.4485% | |
| -64.4864% | |
| -52.6396% | |
| -50.4721% | |
| -28.328% | |
| -5.5704% | |
| 3.7758% | |
| 16.9125% | |
| 16.1954% | |
| 6.707% | |
| 9.8767% | |
| 2.8572% | |
| 6.2455% | |
| 17.412% | |
| 21.3155% | |
| 45.1101% | |
| 70.4846% | |
| 56.7287% | |
| 80.1477% | |
| 91.8197% | |
| 91.9922% | |
| 193.4686% | |
| 224.0743% | |
| 193.7783% | |
| 173.07% | |
| -33.3795% | |
| -52.4074% | |
| -27.0986% | |
| 90.8644% | |
| 205.7699% | |
| 171.5303% | |
| 139.1318% | |
| 112.8645% | |
| 34.616% | |
| -10.027% | |
| -46.8354% | |
| -27.749% | |
| -23.8258% | |
| -12.6946% | |
| 11.4822% | |
| -5.671% | |
| 6.9841% |